| Literature DB >> 31250731 |
Rabha M Younis1, Rachel M Taylor2, Patrick M Beardsley3,4, Joseph L McClay1.
Abstract
The ANKS1B gene was a top finding in genome-wide association studies (GWAS) of antipsychotic drug response. Subsequent GWAS findings for ANKS1B include cognitive ability, educational attainment, body mass index, response to corticosteroids and drug dependence. We review current human association evidence for ANKS1B, in addition to functional studies that include two published mouse knockouts. The several GWAS findings in humans indicate that phenotypically relevant variation is segregating at the ANKS1B locus. ANKS1B shows strong plausibility for involvement in CNS drug response because it encodes a postsynaptic effector protein that mediates long-term changes to neuronal biology. Forthcoming data from large biobanks should further delineate the role of ANKS1B in CNS drug response.Entities:
Keywords: BMI; NMDA; antipsychotics; cognition; corticosteroids; drugs of abuse; glutamatergic neurotransmission; postsynaptic density; serotonin; synapse to nucleus communication; synaptic plasticity
Mesh:
Substances:
Year: 2019 PMID: 31250731 PMCID: PMC6912848 DOI: 10.2217/pgs-2019-0015
Source DB: PubMed Journal: Pharmacogenomics ISSN: 1462-2416 Impact factor: 2.533